A high-quality, naturalistic photograph of a modern, boutique cannabis dispensary interior focusing on a ‘Support Local’ sign.
Walk into a state-legal dispensary and you will find licensed staff, tested products and tax collection like any other business. But in the eyes of one section of the federal tax code, that business has long been treated like a drug cartel. That section is IRS Code 280E, and it has quietly shaped which cannabis businesses survive for more than four decades.

The rules changed in April 2026, when the Department of Justice moved state-licensed medical marijuana and FDA-approved cannabis products to Schedule III. For medical operators, the 280E era is ending; for adult-use businesses, it continues. Here is what the code does, why it matters to consumers, and where things stand now.

What IRS Code 280E Actually Says

Enacted in 1982 to stop drug traffickers from writing off business expenses, 280E disallows all deductions or credits for any business that traffics in controlled substances. Because cannabis sat in Schedule I of the Controlled Substances Act, every state-legal cannabis business was treated as a trafficker by the IRS, regardless of state licensing.
You can read the statute itself on the Legal Information Institute’s page for 26 U.S. Code § 280E, and the Congressional Research Service has published a detailed legal analysis of how it applies to marijuana businesses.
In practice this creates an absurd contrast. A coffee shop deducts its beans, rent, staff wages, electricity and compostable cups. A cannabis shop next door can deduct only its cost of goods sold, essentially the plant itself; rent, payroll, marketing, security and health insurance are all non-deductible. Many operators faced effective tax rates of 60% to 70% of gross income.
A woman working on a laptop with a cannabis leaf logo, illustrating a knowledgeable, stigma-free approach to cannabis education and advocacy.

Why 280E Matters Beyond the Boardroom

The damage spreads well past tax season. Businesses paying most of their income in tax cannot offer living wages or benefits, so budtenders and educators feel the pinch first.
For a broader look at how these tax and policy barriers connect to the wider reform conversation, see our guide to cannabis decriminalization and policy reform.
Even the IRS’s own Taxpayer Advocate Service documented the significant federal income tax challenges marijuana-related businesses face despite operating legally under state law.
It also slows the industry’s sustainability transition, because switching to eco-friendly packaging or regenerative farming takes capital that 280E drains away. And it builds a wall around market entry: without the capital buffers of large corporations, social equity applicants and small craft growers were often priced out before they could compete.

The April 2026 Shift: Medical Marijuana Moves to Schedule III

On April 28, 2026, a DOJ final order took effect moving FDA-approved marijuana products and state-licensed medical marijuana to Schedule III. Because Schedule III substances are not “trafficking in controlled substances” under 280E’s terms, the deduction bar no longer applies to those businesses.
A close-up photograph of a fresh cannabis flower in a glass jar sitting next to a calculator, emphasizing the balance between nature and business numbers.
This is a genuine win for medical operators: dispensaries serving patients can finally deduct ordinary business expenses and reinvest in care. Treasury and the IRS announced the process for tax guidance following the DOJ order, expecting the change to apply to the full 2026 tax year, with guidance on expense apportionment for businesses that hold both medical and adult-use licenses still to come. No retroactive relief for prior years has been granted.
One limitation matters: adult-use cannabis remains on Schedule I, so recreational businesses are still fully subject to 280E. Dual-license operators face a split system, deducting expenses on the medical side while the adult-use side remains barred.

What It Means for Consumers

The code affects shoppers more than most people realize. Higher effective taxes push up shelf prices, thinner margins limit staff training and community programs, and squeezed-out small growers mean less product diversity. The businesses that survived 280E tended to be the best-capitalized, not necessarily the best.
Close-up of a healthy, vibrant cannabis leaf gently held by a person’s hand, highlighting hands-on plant care and sustainable cultivation.
As medical operators recover, expect visible changes: more investment in patient services, sustainable technology like efficient lighting and water reclamation, and competitive pricing. Supporting local, community-focused dispensaries amplifies those reinvestments, and choosing brands with genuine eco-friendly practices keeps pressure on the whole industry.

The Road Ahead

Full removal of 280E for all legal cannabis businesses requires either federal legalization or congressional action, and neither has happened yet. The April 2026 rescheduling resolved the medical side of the problem while leaving adult-use operators in the old regime.
We will keep tracking the IRS guidance on expense apportionment and any further scheduling changes. For consumers, the practical takeaway is simple: the price you pay at the counter has been shaped by a 1982 tax rule, and only now is that shape beginning to change.
Disclaimer: This article is educational and reflects the tax landscape as of November 2026. Tax rules and their application are complex and changing; nothing here is tax or legal advice, and businesses should consult a qualified professional for guidance on their specific situation.